Objective People with Multiple Sclerosis (MS) experience lower levels of quality of life (QOL) than people from the general population. We examined the relative impact of MS-related disabilities on QOL. Method Data were obtained from a sample of 530 patients who completed the Multiple Sclerosis Impact Profile (MSIP), a disability measure based on the International Classification of Functioning, Disabilities and Health (ICF) and two generic health-related QOL measures, the Medical Outcome study Short Form Questionnaire (SF-36) and the World Health Organization Quality Of Life-BREF (WHOQOL-BREF). The impact of disabilities on QOL was estimated using hierarchical multiple regression analyses after controlling for the clinical course of MS.
Introduction
Multiple sclerosis (MS) is a chronic, demyelinating, neurodegenerative disorder of the central nervous system (CNS). Its onset is usually in early adulthood and the course of disease is often progressive and debilitating [1] . Common symptoms include optic nerve dysfunction (e.g., visual failure), sensory disturbance (such as facial pain, sensory level disturbance, numbness, or tingling sensations), pyramidal tract dysfunction (such as increased muscle tone and hyperreflexia), ataxia (such as failure of muscle control in limbs resulting in lack of balance and co-ordination or disturbance of gait), double vision, bladder and/or bowel dysfunction, and sexual dysfunction [1] . In addition, fatigue, cognitive impairment, and depression are often indicated as relevant co-occurring symptoms in MS.
People with MS experience lower quality of life (QoL) levels than people from the general population in health-related QoL domains [2, 3] . MSrelated disabilities are a likely explanation for this poorer QoL. This has been reported for a number of disabilities, such as fatigue [4] [5] [6] , cognitive and emotional functioning [7] , depression [4, 5, 8, 9] , chronic pain [10] , and bladder and sexual dysfunction [11] .
Although these studies generated clinically important information, they are limited in that each study focused on the influence of only one or two disabilities on QoL (univariate analysis). No evidence is available on the relative impact of a number of MS-related disabilities on QoL (multivariate analysis). This evidence could help to understand the impact of MS, and not only of a specific disability, on QoL, which could in turn assist when setting priorities in treatment programs focusing on improvement of QoL with MS. Therefore, the aim of this study is to examine the relative contribution of all known MS-related disabilities on QoL. We have used the international classification of functioning, disabilities and health (ICF) definition for disabilities: "disability is an umbrella term for impairments in body functions and structures, limitations in activities and restrictions in participation" [12] . We controlled for disease course when analyzing the impact of disabilities on QoL. The clinical course of MS can vary from stable, to slowly progressive to rapidly progressive. It is known that disease course can influence QoL, meaning that, all other factors being equal, the more aggressive the disease course, the lower the QoL [13, 14] .
Methods

Samples
We applied a postal survey to two samples of patients with MSmembers of the MS patients' association in the North of the Netherlands (PA sample) and patients from the Groningen MS center, part of the Neurology Department of the University Hospital (UH sample). Respondents could not participate in both samples. Of the 172 questionnaires sent out in the PA sample, 153 questionnaires (89% response rate) were returned and used for analyses. Of the 562 patients in the UH sample, 377 patients (67% response rate) completed the questionnaires. The non-responders in both samples did not differ in age and gender from participating patients.
Measures
Multiple Sclerosis Impact Profile (MSIP)
We applied the MSIP to assess MS-related disabilities [15, 16] . The MSIP is a recently developed measure with established psychometric properties and is based on the International Classification of Functioning, Disability and Health [12] . The MSIP reflects an objectified view of the prevalence and severity of MS-related disabilities and consists of 36 items divided over seven scales and has four additional impairment items. Item scores are graded on three to five-point rating scales with discrete responses, rang-ing from 0 (no disability) to 3 or 4 (complete disability). Scores are summed for each scale. MSIP scores can vary from 0 to 12-24 for the scale variables, and from 0 to 4 for the single impairment items [15] . For reasons of comparability of the scores for each scale and single impairment items, in this study the summed and individual scores were multiplied to obtain a result ranging from 0 to 100.
The MSIP showed satisfactory levels of internal consistency. Cronbach's alphas ranged between 0.49 (environmental factors) and 0.91, whereas the mean inter-item correlations ranged between 0.19 (environmental factors) and 0.65. Test-retest reliability intraclass correlations ranged between 0.65 (environmental factors) and 0.97.
QoL measures
QoL was assessed using two generic health-related QoL measures, the SF-36 and the WHOQOL-BREF. SF-36 consists of eight scales and two separate questions covering physical, psychological, and social aspects of health [17] . Item scores were coded, summed, and transformed to a scale ranging from 0 (worst health) to 100 (best health) for each dimension. In a previous Dutch study of patients with MS [18] , the SF-36 showed satisfactory levels of internal consistency. Cronbach's alphas ranged between 0.69 and 0.93, and test-retest reliability correlation coefficients ranged between 0.48 and 0.87. In our study, Cronbach's alphas ranged between 0.74 and 0.96.
The WHOQOL-BREF [19] was the second QoL measure applied in this study. The WHOQOL-BREF consists of 26 items divided into four domains covering physical, psychological, social, and environmental aspects and has two single-item questions. For each scale, item scores were coded, summed, and transformed to a scale ranging from 0 (worst health) to 20 (best health). In a previous Dutch study [20] , the WHOQOL-BREF showed satisfactory levels of internal consistency. Cronbach's alphas ranged between 0.66 and 0.80. In our study, Cronbach's alphas ranged between 0.63 and 0.81.
Disease course
The various clinical courses of MS can usually be characterized either as episodic acute periods of worsening, or gradually progressive deterioration of neurological functioning, or as a combination of the two [21] . To assess the course of the disease, respondents were asked to choose a description for the course of MS that best suited their case out of five briefly described recognizable disease courses. These descriptions were used to identify whether patients had experienced a stable (with or without relapses), slowly progressive (with or without relapses), or rapidly progressive disease course over the preceding 6 months [13, 22] . Because the disease course subgroups are based on self-reports, they are similar but not equal to distinctions in disease course made by neurologists.
Procedures
Respondents in both samples completed the MSIP [15] , the WHOQOL-BREF [19] , and demographic and disease course questions. In addition, PA sample respondents also completed the SF-36 [17] .
The local University Hospital Medical Ethics Committee approved the research proposals for both studies. Written informed consent from respondents from both samples was obtained.
Analysis
Analysis of variance (ANOVA) for multiple comparisons with post-hoc Bonferroni correction was used to determine statistically significant differences between the disease course subgroups for the continuous variables. For the categorical variables, the k-independent samples test was applied with posthoc analysis for Mann-Whitney U-tests.
Next, the impact of the MS-related disabilities on QoL was assessed using a series of hierarchical regression analyses with each of the QoL scale variables as dependent variables. On the basis of statistically significant correlations of the most important background variables (age, gender, marital status, and educational level) with the QoL dependent variables, age was included as the covariate for five QoL variables and educational level as the covariate for two QoL variables. Before entering variables into the analysis, dummy variables were generated for the categorical variables (disease course and educational level) and for the four single impairment items (fatigue, pain, impairment in speech functions, and impairment in sight functions). Background and disease course variables were then entered in the regression model at the first step and the MSIP-disability variables (all in one) at the second step to determine whether they explained a significant percentage of the variance in QoL. The expected direction of standardized β-weights is negative, meaning that less disability equated to better QoL.
Results
Samples
The characteristics of the PA and UH samples were similar. More detailed information on the comparison of the PA and UH was reported earlier [15] . The results for the whole sample are presented in Table 1 . The characteristics of the disease course sub-samples were similar for most characteristics but differed for employment status and age. As 
Prevalence and severity of disabilities
The prevalence and mean severity scores for the MS-related disabilities are shown in Table 2 .
"Fatigue" was reported as the most severe disability and was also the most prevalent. "Limitations in activities of daily living" was the second most severe disability followed by "limitations in basic movement activities", "impairments in muscle and movement functions" and "impairments in excretion and reproductive functions". As expected, disabilities differed statistically significantly between the disease course subgroups, except for lack of support in environmental factors. Disabilities in patients with rapidly progressive MS were more severe compared with the disabilities in patients with slowly progressive MS, which in turn were more severe than the disabilities in patients with stable MS. Of note, post-hoc analyses were significant for all comparisons between the stable and progressive subgroups. However, only 4 of 11 comparisons between the slowly progressive and rapidly progressive subgroups were significant, meaning that the severity of disabilities were at about the same level in both progressive subgroups except for impairments in muscle and movement functions, basic movement functions, fatigue, and impairments in seeing functions. Table 3 presents the results of the regression analysis designed to explain the relative role of each disability in the prediction of health-related QoL evaluated by the eight SF-36 variables. The disability variables contributed statistically relevantly to a unique segment of the variance for all SF-36 domains, especially social functioning, mental health, and bodily pain.
Impact of disabilities on the SF-36 variables
Most standardized β-weights were in the expected direction and showed that "impairments in mental functions" was a significant predictor for five of eight SF-36 domains, meaning that patients who reported less impairment in mental functions (cognitive, emotional, and sleep functions) reported better QoL in the domains of mental health, emotional functioning, social functioning, bodily pain, and vitality. "Limitation in activities of daily living" The impact of disabilities on QoL in people with MS was an important predictor in social functioning, mental health, and the physical function domains of QoL, meaning that patients who were less limited reported better QoL. "Limitation in basic movement activities" was a significant predictor in the QoL domains for mental health and social functioning. However, on the contrary to expectations, betas were positive here, meaning that patients who were more limited in these activities (such as maintaining or changing the body position, transferring oneself, or in the use of hand and arm) reported better QoL. "Pain" was a significant predictor for the physical functioning and bodily pain QoL domains, with a beta in the expected direction. Finally, "fatigue" was a statistically significant predictor of physical functioning, but showed a positive beta, meaning that a patient with more severe fatigue complaints reported better QoL for this domain.
Impact of disabilities on the WHOQOL-BREF variables
The results of the regression analysis to determine the effect of the various disabilities on healthrelated QoL, evaluated by the four WHOQOL-BREF domains, are presented in Table 4 . The disability variables contributed to a unique segment of the variance for all four QoL domains. The standardized βweights were in the expected direction and showed that "impairments in mental functions" was a significant predictor in all QoL domains and even the most significant predictor in physical health and psychological health, meaning that patients who reported less impairment in mental functions reported a better QoL. The second most important predictor for three of four QoL variables was "lack of support from environmental factors", meaning that patients who reported less lack of support from immediate family, personal assistance or the social security and health services reported better QoL in the psychological health, social relationships, and environment domains. "Restrictions in participation in life situations" was the strongest predictor in the environment QoL domain and the second strongest predictor of psychological health, meaning that patients with fewer restrictions in participation reported better QoL. "Impairments in excretion and reproductive functions" was the most causative predictor for the social relationships QoL domain.
Patients who reported more impairment in excretion and reproductive functions reported a poorer QoL. Furthermore, "limitations in activities of daily living" and "pain" were statistically significant predictors of QoL for physical health.
Discussion
In this study we examined the relative impact of various MS-related disabilities on health-related QoL. Our findings show that "impairment in mental functions" was the most important predictor of health-related QoL. Fatigue was the most severe impairment with the highest prevalence in all disease course subgroups, whereas the impact on QoL was not statistically significant in any of the QoL domains, except for physical functioning evaluated using the SF-36. The results of regression analysis showed that the contribution of disabilities differed for the comparable domains in both QoL measures (i.e., mental health in SF-36 and psychological health in WHOQOL-BREF) indicating that both measures operationalized these dimensions differently. In general, QoL using the SF-36 was sensitive to the MSIP "impairments in body functions" and the "limitations in activities" disability variables, whereas QoL measured by the WHOQOL-BREF was also sensitive to the "restrictions in participation" and "lack of support of environmental factors" variables. These differences between the QoL measures can be explained by the background of both measuresthe SF-36 originated in the early days of QoL measurement development in which the focus was on physical functioning, whereas the WHOQOL-BREF is a more recently developed measure based on a broader and more balanced definition of QoL, which includes participation in life situations and the influence of the environment.
Our findings of a very high prevalence and severity for fatigue confirmed findings in earlier studies [23] . However, on the contrary to earlier findings, fatigue in our study showed a limited impact on QoL compared with other studies examining the impact of fatigue on QoL [5, 6] . An explanation may be that the effect of fatigue on QoL is mediated by the effect of other MS-related impairments on QoL. Previous studies of the effect of single impairments on QoL were unable to adjust for this mediating effect.
Impairments in mental functions, including impairments in cognitive, emotional, and sleep functions, were reported by more than 80% of the respondents in the total sample. Therefore, their prevalence is far higher than findings in earlier studies performed on cognitive impairments (40-65%) [24, 25] and depression (lifetime prevalence of 50% and annual prevalence of 20%) [26] . A possible explanation could be the combination of both aspects into one variable "mental functioning". Earlier findings that cognitive impairments have a major impact on all aspects of QoL [24, 25] were confirmed in our study. The same holds true for the impact of depression on QoL [4, 5, 8, 9] . The high prevalence of impairments in excretion and reproductive functions found in earlier studies [27] was confirmed in this study. Bowel and bladder dysfunctions were related to a reduced quality of social functioning [11, 28] . This is confirmed by our findingswhen QoL is evaluated using the WHOQOL-BREF. Sexual disturbance was associated with a reduced quality of mental health [11, 29] , which could not be confirmed by our findings -"excretion and reproductive functions" was the most important explanatory aspect of QoL concerning social relationships (WHOQOL-BREF), but showed no statistically significant contribution to mental health (SF-36) or psychological health (WHOQOL-BREF). The prevalence of pain in our sample matched results in earlier studies [10, 30] . These studies also reported that pain is particularly correlated with the mental health and physical functioning aspects of QoL. In our study, pain was the most causative variable in QoL related to physical functioning (SF-36), physical health (WHOQOL-BREF), and bodily pain (SF-36), but showed no significant contribution to mental health (SF-36) or psychological health (WHOQOL-BREF).
We found some statistically significantly positive betas (i.e., more disability = better QoL) for the MSIP "limitations in basic movement activities" in the SF-36 social functioning and mental health variables, and for "fatigue" in the SF-36 physical functioning variable, where a negative beta was expected. A possible explanation could be the inter-item correlation between the MSIP variables. As we entered the MSIP variables at the same time (all in one) in the regression model (multivariate analysis), these correlations could explain the positive betas as a case of confounding correlations between the MSIP variables, meaning that effects of the separate disabilities can be influenced by the effects of other MSrelated disabilities. We, therefore, applied the MSIP variables with a positive beta as a single explaining variable in the regression model (univariate analysis). The direction in two of the three betas thereby reversed to statistically not significant values, and the direction of the third beta (the limitations in basic movement activities for the social functioning variable) changed to the expected negative direction (see figures between brackets in Table 3 ). Another explanation for these unexpected results can be the finding that the impact on QoL appeared to be dependent on the applied QoL measure. The WHOQOL-BREF was sensitive to disabilities related to all four ICF components, whereas the SF-36 was only sensitive to disabilities in the body functions and activities components and not for disabilities in the participation and environmental factors components. Interestingly, we only found positive betas using the SF-36 as the outcome. Apparently, the WHOQOL-BREF is better able to measure the effect of each disability separately.
Methodological considerations
We succeeded in obtaining data from a representative sample of people with MS as regards the number of respondents, demographic variables, and disease-related variables (years from diagnosis and disease course). The unusually high response rate in the PA sample (89%) is probably because of the fact that these respondents were participating in another longitudinal study and we did not approach non-responders or dropouts. Therefore, we assume that at the time of our measurement, patients in the PA sample were highly motivated and willing to complete our questionnaires. Patient characteristics from both PA and UH samples were similar to what has already been published [15] .
One issue that may limit the representativeness of our findings is that the number of patients (5%) who reported a rapidly progressive disease course was limited. Although it is known that a minority of patients (prevalence about 15%) have primary progressive MS [31] , this sub-sample was probably less representative for patients with a primary progressive disease course.
Furthermore, there might have been some scaling bias or systematic bias because of the use of self-report questionnaires, but their effect on the final results is probably neutralized through the application of self-report questionnaires in the disability and the QoL evaluation.
Implications
This study generated new evidence on the relative impact of various disabilities on health-related QoL. As disabilities in mental functions turned out to have the largest impact on QoL and also showed a high prevalence among patients with MS (more than 80%), professionals should be aware of this finding. Further work is needed to explore whether interventions with the intention to try and improve cognitive functioning can improve QoL as well as cognitive functioning. Furthermore, treatment programs should give priority to interventions concerning impairments in emotional functioning and sleep, as both aspects are relevant aspects of mental functioning.
Their effects are best evaluated using the WHOQOL-BREF because this measure seems more sensitive to reflect the impact of disabilities on QoL.
